What's Inside

Scientists from big pharma are incorporating AI into their R&D processes to identify potential safety red flags earlier on in the development pipeline. 

In this report, we showcase how AI-powered drug discovery can help reduce safety-related drug attrition.

• Can we trust AI as a collaborative scientific tool?
• Applications of AI in accelerating preclinical safety and toxicity assessments.
• Real-world examples of how AI could help prevent late-stage failures and FDA-withdrawals.